نتایج جستجو برای: myocardial biomarkers
تعداد نتایج: 255279 فیلتر نتایج به سال:
Abstract Background Acute myocardial infarction (AMI) is a leading cause of death worldwide. The first hours acute are correlated with the highest risk death. Therefore, early diagnosis seriously affects efficacy treatment administered to patient. Misdiagnosing patients chest pain often leads inappropriate admission them as patients. physical examination patient, electrocardiogram, and assessme...
myocardial infarction (mi) is one of the most important health burdens worldwide. aspirin as an non- steroid anti—inflammatory drug, has been proven to be a protective factor to decrease the incidence, however its effect of mi size is still unknown. we designed this study to compare the biomarkers after mi in patients with and without aspirin intake. 378 patients were enrolled and the results s...
BACKGROUND Although the release of cardiac biomarkers after percutaneous (PCI) or surgical revascularization (CABG) is common, its prognostic significance is not known. Questions remain about the mechanisms and degree of correlation between the release, the volume of myocardial tissue loss, and the long-term significance. Delayed-enhancement of cardiac magnetic resonance (CMR) consistently quan...
department with symptoms of chest pain cannot perform adequate treadmill exercise. In these patients we perform vasodilator myocardial perfusion imaging. Our study examined the usefulness of resting myocardial perfusion imaging alone for triaging patients with chest pain and nondiagnostic electrocardiograms. We believe that optimal protocols for evaluating patients with chest pain in emergency ...
With the improvement of cancer therapy, survival related to malignancy has improved, but the prevalence of long-term cardiotoxicity has also increased. Cancer therapies with known cardiac toxicity include anthracyclines, biologic agents (trastuzumab), and multikinase inhibitors (sunitinib). The most frequent presentation of cardiac toxicity is dilated cardiomyopathy associated with poorest prog...
Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. The primary prevention of CVD is dependent upon the ability to identify high-risk individuals long before the development of overt events. This highlights the need for accurate risk stratification. An increasing number of novel biomarkers have been identified to predict cardiovascular events. Biomarkers play a ...
OBJECTIVE Acute myocardial infarction (AMI) is a most serious cardiovascular disease with high morbidity and mortality. Novel biomarkers for AMI are explored continuous. MicroRNAs (miRNAs, miRs) are present in the circulation in a consistent, stable, and reproducible manner, attracting major interest of using circulating miRNAs as biomarkers. In plasma, miR-208a and miR-499 are considered to be...
Biomarkers are becoming increasingly more important in clinical decision-making, as well as basic science. Diagnosing myocardial infarction (MI) is largely driven by detecting cardiac-specific proteins in patients' serum or plasma as an indicator of myocardial injury. Having recently shown that cardiac myosin binding protein-C (cMyBP-C) is detectable in the serum after MI, we have proposed it a...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید